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Abstract
The importance of dietary intake in the treatment of type 2 diabetes was emphasized. This study was performed to investigate the dietary intakes
of Korean type 2 diabetes patients according to the treatment and duration of diabetes and to examine the relationships between their diet and
serum lipid profiles. The subjects were 111 type 2 diabetic patients who were treated by medical nutrition therapy only, oral hypoglycemic agents
(OHA), or insulin with medical nutrition therapy. Dietary intake was assessed by a registered dietitian using semi-quantitative food frequency questionnaires.
Comparisons according to treatment type were made using covariance analyses. General linear models identified the independent effects of the different
treatments after covarying for age, duration of diabetes, and 2-way interactions. There were no significant differences in age and BMI but was
in duration of diabetes according to treatment type in these subjects. Carbohydrate to energy ratio was higher in the OHA group (P< 0.05), whereas
the fat to energy ratio was higher in the insulin group for males (P< 0.05). Carbohydrate (R
2 =0 . 2 4 ,  P= 0.005) and fat (R
2 =0 . 2 6 ,  P=0 . 0 2 )  t o
energy ratios were independently associated with the duration of diabetes after covarying for age, sex, treatment, and 2-way interactions. The levels
of triglyceride (TG; R
2 =0 . 3 2 ,  P= 0.02) and total cholesterol (TC) were associated independently with energy intake and the carbohydrate (R
2 =
0.15, P= 0.02) and fat (R
2 = 0.15, P= 0.01) to energy ratios, respectively. The concern that the independent association of dietary intake with either
duration of diabetes or dietary factors affects blood lipid levels could suggest that specific dietary recommendations may work better for identifiable
groups of diabetes patients. 
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Introduction10)
The prevalence of diabetes in the world was estimated to be 
2.8% in 2000 and 4.4% in 2030 [1]. In Korea, diabetes is a 
major chronic disease, and its incidence has risen dramatically. 
The mortality rate due to diabetes from 1995 to 2005 increased 
2-fold in Korea [2]. The main cause can be attributed to obesity 
stemming from changes in Korean dietary patterns [3]. The intake 
of fat and animal foods has increased remarkably [4]. 
Dietary intake plays a role in both the origin and treatment 
of diabetes. Medical nutrition therapy (MNT) is a basic treatment 
for diabetes that aims to reduce body weight and help optimize 
metabolic control [5]. Fasting glucose levels fall rapidly within 
the first 3 to 14 days of diet therapy, and as little as a 5% 
reduction in body weight may be associated with significant 
improvements in glycemic control [6]. However, only 15% of 
patients can achieve and sustain a normal fasting glucose level 
with diet therapy alone [7]. When the target glycemic control 
level is not achieved after 2-3 months of MNT, pharmacotherapy 
is considered [8]. Even during pharmacotherapy or the insulin 
treatment period, MNT is important for controlling one’s body 
weight and metabolism. Many studies have examined the 
relationship between diet and drug interactions in diabetes [9,10]. 
Much controversy exists about the relationship between the 
amount and types of dietary fat and carbohydrates and the risk 
for diabetes. There are no clear recommendations on the appropriate 
macronutrient composition for reducing risk for diabetes. 
Increased energy intake is most likely to blame for insulin 
resistance through the production of obesity. As such, energy 
restriction may be the best nutritional approach for the treatment 
of insulin resistance. Intake of dietary fat, particularly saturated 
fat, appears to be associated with insulin resistance and may 
predispose oneself to the development of diabetes [11,12]. Diets 
high in monounsaturated and polyunsaturated fatty acids were 
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shown to have beneficial effects on glucose control and insulin 
sensitivity relative to low-fat, high-carbohydrate diets [13,14]. 
However, other studies suggested that there is no association 
between increased risk for type 2 diabetes and total dietary fat 
intake or intake of specific types of fatty acids [15]. The role 
of dietary carbohydrates in insulin resistance has been debated. 
Samaha et al. [16] reported that low-carbohydrate diets improved 
insulin sensitivity. But, there is no association between total 
carbohydrate intake and diabetes risk [17-19], and other studies 
reported that total
  carbohydrate intake is inversely related to 
HOMA-IR [20].
Current dietary guidelines are recommended for the general 
population, but emerging evidence suggests an individualized 
approach involving MNT in accordance with the specific 
conditions. MNT for Korean individuals with diabetes mellitus 
involves treatment using dietary choices that consider Korean 
dietary patterns, treatment, and duration.
In this study, we aimed to investigate the dietary intake of 
Korean patients with type 2 diabetes according to treatment type 
and duration and examine the effects of changing dietary intakes 
on the metabolic risk for diabetes. 
Subjects and Methods
Protocol and subjects
The subjects were type 2 diabetes patients treated with medical 
nutrition therapy (MNT group) alone, oral hypoglycemic agents 
(OHA group), or insulin (combination therapy or single therapy; 
insulin group) in addition to MNT. The subjects with diabetes 
were treated at Kyung Hee Medical Center. We investigated each 
subject’s family history of diabetes, disease duration, treatment 
method, and medication via interview with a questionnaire. Blood 
pressures were also measured. Subjects were excluded if they 
had abnormal renal or liver function or had gastrointestinal 
disease. The protocol and consent forms for the study were 
approved by the ethics review board of the Kyung Hee Medical 
Center, and each volunteer was informed about the study and 
agreed to participate by reading and signing the approved consent 
form. 
Anthropometric measurements and dietary assessment
Body weight was measured to the nearest 0.1 kg and height 
to the nearest 0.1 cm using an appropriately calibrated scale and 
stadiometer. BMI and percent of ideal body weight (PIBW) were 
calculated. Subjects’ dietary intakes were assessed by a well- 
trained registered dietitian using semi-quantitative food frequency 
questionnaire (SFFQ). The SFFQ was validated in a pilot study 
carried out with 20 men and women who visited the hospital 
for health screening. The SFFQ was compared
  with a 3-d diet 
record and was shown to provide a reasonable
  measure. Each 
subject was asked to report their usual frequency
  of consumption 
and usual portion size over the past year. The frequencies of 
consumption were measured on a 9-grade scale:
  never, 1 time/mo, 
2 times/mo, 1 time/wk, 3 times/wk, 5 times/wk,
  1 time/d, 2 
times/d, and 3 times/d. During
  the interview, food models and 
reference utensils were shown
  to the subjects so that they could 
estimate portion size. Nutrient intake based on this information 
was calculated from
  food-composition tables in Korea [21].
  Daily 
nutrient intake was calculated by multiplying the nutrient
  content 
of the specified portion of each food item by the frequency
  of 
its daily consumption and summing all the items. 
Blood sampling and biochemical assessment
Blood samples were drawn in the morning after fasting 
overnight and were centrifuged to obtain plasma, which was 
stored at -70℃ until analyzed. Plasma concentrations of glucose, 
triglycerides (TG), and total cholesterol (T-Chol) were analyzed 
by a Reflotron System (Boehringer Mannheim, Germany). High 
density lipoprotein cholesterol (HDLC) was analyzed by an 
enzymatic method after precipitation with phosphotungstate and 
magnesium cation. Hemoglobin A1c (HgA1c) was measured 
using a Hematology Analyzer (IMX, USA) with micro-particle 
enzyme immunoassay kit (Astx-shield CO., Norway). Contents 
of low density lipoprotein cholesterol (VLDLC) and low density 
lipoprotein cholesterol (LDLC) were calculated by Fridewald 
calculation. 
Statistical analysis
Group data are presented as means ± SD. Comparisons between 
treatment types were made by analyses of covariance. A P-value 
< 0.05 was chosen as the level of significance. General linear 
model (GLM) was used in the analyses to identify independent 
associations of dietary intake after covarying for age, treatment, 
sex, and duration, on metabolic risk factors. Independent effects 
of duration on dietary intake were identified after adjusting for 
age, sex, treatment, and 2-way interactions. Model coefficients 
were tested for significance. Residuals from the GLM were 
checked for normality. All analyses were performed with SAS 
9.1 for Windows (SAS Institute Inc, Cary, NC).
Results
General characteristics of subjects
The subject characteristics are presented in Table 1. There were 
no differences between the treatment groups according to age, 
weight, height, body mass index (BMI), and percent of ideal body 
weight (PIBW). The percentage of BMI higher than 23, which 
is the cutoff for being overweight in Korea, was 68.5%, and 







Gender (male% / female%) 55/45 51/49  26/74
Age (yrs) 54.4 ± 13.0 56.9 ± 12.9 56.5 ± 6.9
Duration (yrs) 2.7 ± 5.0
a 6.7 ± 7.3
ab 11.2 ± 8.5
b
Weight (kg) 63.9 ± 11.3 65.1 ± 11.3 64.4 ± 7.7
Height (cm) 161.2 ± 8.0 161.7 ± 8.7 159.4 ± 7.0
BMI (kg/m
2) 24.4 ± 2.8 24.8 ± 3.0 25.4 ± 3.0
PIBW (%) 113.4 ± 12.6 115.3 ± 13.9 119.6 ± 15.7
Values  are  means ± SD. 
Values  with  different  superscript  letters  are  significantly  different  at  P < 0.05. 
M N T , m e d ic a l n u t ritio n  t h e ra p y  o n ly ; O H A , o ra l h y p o g ly c e m ic  a g ent  treatment  in 
addition to MNT; INS, insulin treatment in addition to MNT; BMI, body mass index; 
PIBW,  percent  of  ideal  body  weight
Table 1. General characteristics of subjects
Male Female
M N T  ( n=1 0 ) O H A  ( n=2 1 ) I N S  ( n=3 ) M N T  ( n=9 ) O H A  ( n=2 1 ) I N S  ( n=9 )
Energy (kcal) 2,517.7 ± 868.2 2,443.1 ± 715.4 2,194.2 ± 489.0 1,995.0 ± 377.6 1,926.6 ± 477.2 1,711.6 ± 283.9
CHO (g) 351.4 ± 109.6 379.0 ± 89.6 284.5 ± 62.7 332.2 ± 79.0 313.7 ± 83.0 283.2 ± 57.3
Protein (g) 61.7 ± 11.4 70.3 ± 9.6 65.5 ± 14.7 65.4 ± 11.6 63.4 ± 11.6 59.9 ± 7.7
Fat (g) 65.8 ± 31.0 56.0 ± 25.0 63.5 ± 5.7 44.9 ± 12.7 45.0 ± 16.9 35.0 ± 7.3
CHO : Pro : Fat (E %) 63
ab  : 11 : 26 66
a  : 12 : 22 58
b  : 13 : 29 67 : 13 : 20 66 : 13 : 21 67 : 14 : 19
Alcohol (Kcal) 8.4 ± 11.0 4.1 ± 7.2 9.1 ± 9.6 0.0 ± 0.0 0.7 ± 1.8 0.2 ± 0.7
Values  are  means ± SD. 
Values  with  different  superscript  letters  are  significantly  different  at  P < 0.05. 
MNT, medical nutrition therapy only; OHA, oral hypoglycemic agent treatment in addition to MNT; INS, insulin treatment in addition to MNT; CHO, carbohydrate; Pro, protein
Table 2. Daily energy nutrient intakes according to treatment type
CHO % Protein % Fat %
Duration -0.3 ± 0.1 (P = 0.005) 0.03 ± 0.04 (P= 0.47) 0.3 ± 0.1 (P =0 . 0 2 )
Age 0.1 ± 0.1 (P= 0.05) 0.03 ± 0.02 (P= 0.21) -0.1 ± 0.06 (P =0 . 0 2 )
Treatments* INS : -7.5 ± 3.3
MNT : -5.2 ± 2.1
(P =0 . 2 2 )
INS : 0.5 ± 1.5
MNT : -0.5 ± 0.9
(P=0 . 6 7 )
INS : 7.0 ± 3.5
MNT : 5.8 ± 2.2
(P=0 . 2 5 )
Sex** F : -0.9 ± 1.7 (P = 0.005) F : 0.8 ± 0.7 (P = 0.13) F : 0.1 ± 1.8 (P= 0.001)
Treatments × Sex*** INS × F : 10.3 ± 4.0
MNT × F : 5.8 ± 3.0
(P =0 . 0 2 )
INS × F : 0.3 ± 1.7
MNT × F : 0.5 ± 1.3
(P=0 . 9 3 )
INS × F : -10.6 ± 4.2
MNT × F : -6.3 ± 3.2
(P=0 . 0 2 )
Intercept 61.7 ± 3.2 (P< 0.001) 10.7 ± 1.4 (P < 0.001) 27.5 ± 3.3 (P < 0.001)
R
2 0.24 0.13 0.26
SEE 5.4 2.3 5.7
Using a general linear model, the relationship between duration and carbohydrate, protein, and fat percentages of the total calorie intake was assessed covarying for age, 
treatment,  sex,  and  treatment-by-sex.
Values  are  regression  coefficients ± SEE  (P v a l u e ) .
CHO,  carbohydrate;  Duration,  duration  of  diabetes;  Treatment,  the  types  of  treatments;  INS,  insulin  treatment  with  MNT;  MNT,  only  medical  nutrition  therapy;  OHA,  oral 
hypoglycemic  agents  treatment  with  MNT;  F,  female;  M,  male
Adjusted  variables  were  duration,  treatments,  age,  sex,  and  2-way  interactions  analyzed  by  GLM. 
* D u m m y  c o d e s  a r e  0=O H A .
**Dummy  codes  are  0 = Male.
***Interaction  variable  between  treatments  and  sex
Table 3. Independent association of duration with carbohydrate, protein, and fat to energy percentage ratios 
obesity in Korea, was 40.5% in Korean individuals with diabetes. 
The duration of diabetes was the longest in the insulin group 
and shortest in the MNT group.
Daily dietary intake according to treatment type
Daily energy and nutrient intakes are presented in Table 2. 
Energy intakes were almost identical among the three groups. 
For the men, there was an independent association between 
treatment type and carbohydrate and fat percentage of total 
energy intake. OHA group had a higher carbohydrate percentage 
of total energy intake, whereas the insulin group had a higher 
fat percentage of total energy intake. For the women, there was 
no significant difference between the groups. 
Independent association of duration with carbohydrate, protein, 
and fat percentages of total energy intake
Using a general linear model, the relationship between duration 
and carbohydrate, protein, and fat percentages of the total calorie 
intake was assessed (Table 3), and the significance of each 
covariate (age, treatment, sex, and treatment-by-sex) was tested. 
Independent associations were observed for duration with 
carbohydrate and fat percentages of total energy intake. 
Carbohydrate percentage of the total energy intake decreased 
(-0.3% per 1 year of diabetes duration), whereas the fat 
percentage of total energy intake increased with duration of 
diabetes (0.3% per 1 year of diabetes duration; Fig. 1). No 
independent associations were found for duration with protein 
percentage of total energy intake. 160 Type 2 DM treatment and dietary intakes
Fig. 1. Comparision of carbohydrate (-0.3% per 1year) and fat percentages 







FBG (mg/dL) 184.0 ± 75.3 173.7 ± 66.7 177.3 ± 105.2
PP2 (mg/dL) 193.9 ± 79.4 215.1 ± 87.0 257.2 ± 106.2
HbA1c (%) 6.7 ± 1.9
a 7.3 ± 1.4
a 8.4 ± 1.1
b
Triglyceride (mg/dL) 216.7 ± 136.0
a 135.1 ± 68.9
b 96.5 ± 43.9
b
T-Chol (mg/dL) 191.7 ± 44.5 184.6 ± 40.6 189.6 ± 37.3
VLDLC (mg/dL) 43.3 ± 27.2
a 27.0 ± 13.8
b 19.3 ± 8.8
b
HDLC (mg/dL) 41.4 ± 11.6
a 42.5 ± 9.6
a 52.0 ± 15.6
b
LDLC (mg/dL) 110.5 ± 36.2 113.5 ± 32.0 126.5 ± 40.1
Hemoglobin(g/dL) 14.1 ± 2.2 14.0 ± 1.9 13.9 ± 0.8
Hematocrit (%) 41.3 ± 6.1 41.4 ± 5.1 41.2 ± 2.4
Total-Protein (g/dL) 7.1 ± 0.5 6.8 ± 0.6 6.8 ± 0.5
Albumin (g/dL) 4.3 ± 0.3 4.1 ± 0.5 4.0 ± 0.5
Values  are  regression  means ± SD. 
Values  with  different  superscript  letters  are  significantly  different  at  P < 0.05. 
MNT, medical nutrition therapy only; OHA, oral hypoglycemic agents treatment in 
addition  to  MNT;  INS,  insulin  treatment  in  addition  to  MNT;  FBG,  fasting  blood 
glucose; PP2, postprandial glucose after 2 hours; HbA1c, hemoglobin A1c; T-Chol, 
t o t a l  c h o l e s t e r o l ;  V L D L C ,  v e r y  lo w  d e n s i t y  l ip o p r o t e in  c h o l e s t er o l ;  H D L C ,  h i g h  
density lipoprotein  cholesterol; LDLC, low density lipoprotein  cholesterol
Table 4. Clinical characteristics of subjects
Triglycerides Total cholesterol
Energy intakes 0.04 ± 0.02 (P= 0.02) -0.02 ± 0.01 (P =0 . 1 9 )
CHO percents - 7.5 ± 3.2 (P= 0.02)
Fat percents - 8.1 ± 3.1 (P= 0.01)
Duration -0.5 ± 1.7 (P= 0.79) 1.3 ± 0.8 (P= 0.11)
Age -1.0 ± 0.9 (P= 0.28) -0.4 ± 0.4 (P=0 . 3 8 )
Treatments* INS : -22.6 ± 31.7 INS : 1.9 ± 14.5
MNT : 76.9 ± 25.9 MNT : 10.1 ± 12.1
(P=0 . 0 1 ) ( P =0 . 7 1 )
Sex** F : -6.7 ± 23.8 (P = 0.78) F : 2.5 ± 11.2 (P =0 . 8 2 )




The relationship between dietary intake and metabolic risk factors was assessed 
after  adjusting  for  duration,  age,  treatment,  and  sex.
Values  are  regression  coefficients ± SEE  (P v a lu e ) . 
CHO  percents,  carbohydrate  percents  from  energy  intakes;  Fat  percents,  fat 
percents from energy intakes; Duration, duration of diabetes; Treatment, the types 
of treatments; INS, insulin treatment with MNT; MNT, only medical nutrition therapy; 
OHA,  oral  hypoglycemic  agents  treatment  with  MNT;  F,  female;  M, m a l e
Adjusted variables were age, treatments, and sex analyzed by general linear model 
(GLM). 
* D u m m y  c o d e s  a r e  0=O H A .
* * D u m m y  c o d e s  a r e  0=M a le .
Table 5. Independent association of energy intake or carbohydrate and fat 
energy ratios with triglycerides and total cholesterol 
Clinical characteristics according to treatment type and duration
The mean values of clinical characteristics according to 
treatment type are presented in Table 4. There were no 
differences in fasting glucose, postprandial 2 hours glucose, 
T-Chol, LDLC, hemoglobin, hematocrit, total-protein, and 
albumin levels according to treatment type. The levels of HgA1c 
and HDLC were higher in the insulin group than the MNT and 
OHA groups. However, the level of HgA1c adjusted for duration, 
age, and sex was not higher in the insulin group compared to 
the other groups. TG and VLDLC levels were higher in the MNT 
group than the OHA and insulin groups. HgA1c and LDLC were 
independently associated with duration after covarying for age, 
sex, and treatment type.
Independent association of dietary intake with metabolic risk 
factors
The relationship between dietary intake and metabolic risk 
factors was assessed (Table 5). Independents associations were 
observed between calorie intake and TG level, and between 
carbohydrate and fat percentages of total energy intake with 
T-Chol level after adjusting for duration, age, treatment, and sex.
Discussion
It is recognized that dietary intake is important not only for 
the prevention but also the treatment of diabetes. In the current 
study on Korean type 2 diabetes patients, we found that the 
carbohydrate and fat to energy ratios were different according 
to the treatment type (MNT, OHA, and insulin) and duration 
of diabetes. In men, carbohydrate percentage of total energy 
intake was higher in the OHA group, whereas the fat percentage 
of energy intake was higher in the insulin group. Carbohydrate 
percentage of energy intake decreased, whereas fat percentage 
increased according to duration of diabetes. We also found an 
association between dietary intakes with metabolic risk factors 
in Korean individuals with diabetes. Energy intake was 
independently associated with the level of TG, and carbohydrate 
and fat percentages of total calorie intake was associated with 
the level of T-Chol. Dietary intake was also critical to metabolism 
and treatment of diabetes. Therefore, we speculate that more 
specific dietary intake recommendations according to treatment 
type and duration could be helpful for treating Korean individuals Jung-Eun Yim et al. 161
with diabetes. 
The characteristics of Korean diabetes are different from 
Western diabetes. Insulin resistance in Westerners is complicated 
by the coexistence of obesity in 80% of patients with type 2 
diabetes [22], but prevalence of obesity in type 2 diabetes was 
only 40% in Koreans [23]. In this study, the prevalence of obesity 
was 41% of diabetes patients and the total energy intakes were 
2,392 kcal and 1,880 kcal in men and women, respectively. 
Reduction of energy intake is the most basic principle used in 
weight loss and diminishing insulin resistance. Further, reduced 
energy intake is associated with acute improvements in glycemic 
control, and it has the potential to benefit long-term metabolic 
control [24]. The mechanism of glycemic control can be explained 
by reduction of hepatic glucose output [5]. However, the contri-
bution of insulin secretion to future weight loss and response 
to hypocaloric diets is controversial, and its effects are difficult 
to isolate from insulin resistance [25]. Reduced caloric intake 
positively affects dyslipidemia. Fifty percent of all diabetic 
patients have abnormal plasma lipid and lipoprotein levels, most 
commonly elevated triglyceride levels and reduced high density 
lipoprotein (HDL) cholesterol levels. TG levels typically fall 
maximally within 2 to 4 weeks of hypocaloric therapy, even in 
patients who do not show improved glycemic control [6]. In this 
study, energy intake was independently associated with the level 
of TG. There are needed to investigate the restriction of energy 
intake considering 60% of Korean patients with diabetes were 
not obese. 
The association between dietary
  fat or carbohydrate content 
and insulin resistance is a topic of academic debate [26]. 
However, there are no clear recommendations on the appropriate 
macronutrient composition for reducing metabolic risk factors. 
Generally, carbohydrate intake represents 50~60% of the total 
caloric amount, and lipids no more than 35%, of Westerners with 
type 2 diabetes [27]. In the second edition of the Guidelines for 
Diet Therapy for Diabetes in Korea [28], the recommended 
intakes of carbohydrates, protein, and fat are 55~60%, 14~20%, 
and 20~25%, respectively. In our study, diabetes patients had 
58~67% carbohydrate of total energy intake. Especially in the 
OHA group, the percentage of carbohydrate intake of the total 
energy intake was high. 
The Korean traditional dietary pattern, characterized by high 
carbohydrate and low fat content, was previously compared with 
the Western diet. The average energy composition
  of the Korean 
diet was found to be 64.5% carbohydrates,
  15.6% protein, and 
20.5% total fat [29]. High carbohydrate
  intake in the Korean 
diet is mainly due to rice intake [30]. Otherwise, low fat intake 
can be explained by cooking methods and traditional dietary
 
patterns, which
  typically comprise steamed rice, soup, kimchi, 
cooked or uncooked
  vegetables, and roasted or broiled meat or 
fish [31]. A higher carbohydrate ratio implies that Koreans with 
type 2 diabetes respond differently to acarbose compared to North 
Americans and Europeans [10]. The role of dietary carbohydrates 
in insulin resistance has been debated. High carbohydrate diets 
do not adversely affect insulin sensitivity [32,33]. McKeown et 
al. [34] found no association between total carbohydrate intake
 
and HOMA-IR. Conversely, Lau et al. [20] reported that total
 
carbohydrate intake is inversely related to HOMA-IR in Danish 
men
  and women. Several epidemiological studies [17-19] found 
that total carbohydrate intake is unrelated to fasting
  insulin and 
diabetes risk. In our study, there was no association between 
carbohydrates ratio of total energy intake and levels of fasting 
glucose, insulin, and HOMA-IR, although carbohydrate of total 
energy intake were associated with the level of T-Chol. 
Additional research is needed to clarify the long-term efficacy 
of carbohydrate restriction in Korean patients with diabetes. 
A diet low in fat is commonly recommended for patients with 
type 2 diabetes to reduce the risk of atherosclerotic disease and 
to treat obesity. High intake of dietary fat, particularly saturated 
fat, was shown in some of studies to be associated with reduced 
insulin sensitivity [35,36]. In this study, fat percentages were 
higher than 25% in the MNT and insulin groups of men. 
Considering insulin therapy associated with weight gain [37], 
there is a need for additional fat restriction in insulin group. We 
also found that according to the duration of diabetes, the 
carbohydrate percentage of total energy intake diminished, 
whereas the fat percentage of total energy intake increased. And, 
fat percentages of total energy intake were associated with the 
level of T-Chol in this study. This means that Korean individuals 
with diabetes must carefully control their fat intake according 
to duration and treatment type. 
This study was limited by inadequate dietary assessment, a 
small number of subjects, and incomplete control of confounding 
variables. Further, dietary intake was influenced by the physical 
activity and/or inactivity, for which no independent measures were 
acquired. The types of fat, such as saturated fat, polyunsaturated 
fat, monounsaturated fat, ingested as well as the glycemic index 
influenced metabolic risk factors. Additionally, the presence of 
unreported and undiagnosed conditions and dietary intakes that 
could affect metabolic risk of diabetes cannot be ruled out. 
The independent association of dietary intake with treatment 
type and duration suggest that specific dietary recommendations 
may work better for identifiable groups of diabetes patients. Thus, 
a variety of strategies are needed for improvement of dietary 
intake recommendations. 
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